Annual Community College Program Day Organizing Committee Sonia Wallman – Executive Director NBC2 Elaine Johnson – Bio-Link Director Russ Read – National Center, NC BioNetwork Lance Hartford – MassBioEd Foundation Margaret Bryans – PI NBC2, Montgomery County Community College Lisa Seidman – Madison Area Technical College Tim Dubuque - NBC2
Massachusetts BioPharma Employment Continues Growth The industry weathered the 2009 downturn without an employment drop. 53% Growth since 2002 Source: U.S. Census, County Business Patterns and MassBio formula and analysis. *2011 figure is a preliminary estimate based on review of Massachusetts ES-202 data for 2010-2011.
Biotechnology R&D Employment According to the Bureau of Labor Statistics’ Quarterly Census of Employment & Wage (QCEW) data, Massachusetts leads the nation in biotechnology research & development employment. Source: U.S. Bureau of Labor Statistics, Quarterly Census of Employment and Wages (QCEW)
Drug Development Pipeline, August 2011 Pre-Clinical316 Phase I216 Phase II275 Phase III76 Pending Approval14 Candidate medicines of Massachusetts-headquartered* companies, by clinical trials stage Massachusetts-headquartered companies’ share of U.S. and Global drug development pipeline * There are many drugs in development in Massachusetts by companies with headquarters located outside of Massachusetts. These candidate drugs are not included in any Massachusetts pipeline estimates found in this report. Massachusetts- headquartered companies* account for about 10% of the U.S. drug development pipeline and 5% of the global pipeline. Source: MedTrack Online, Life Sciences Analytics, Inc.
Of the 897 drugs in the Massachusetts pipeline, 42.7% are cancer drugs. Drugs intended for the Central Nervous System (CNS) therapeutic area are next at 10.1% of the pipeline. Massachusetts Pipeline by Therapeutic Area Source: MedTrack Online, Life Sciences Analytics, Inc.
Source Data: 2011 PricewaterhouseCoopers, National Venture Capital Association, MoneyTree TM Report, Historical Trend Data, and MassBio analysis. Venture Capital Investment $1.071 billion invested in MA biotechs in 2011 is an historic high. $8.054 billion since 2002
Source: 2011 PricewaterhouseCoopers, National Venture Capital Association, MoneyTree TM Report, Historical Trend Data, MassBio analysis. MA Share of the Biotech VC Dollar MA biotechs received 22.6% of all VC biotech financing, just below the 2010 all-time high.
Leading BioPharma Employers (MA), 2011 1. Genzyme (Sanofi)4,356 2. Pfizer2,600 3. Biogen Idec2,300 4. Novartis2,100 5. Thermo Fisher Scientific1,700 6. Shire1,500 7. Vertex1,310 8. EMD Millipore 1,237 9. Parexel International1,200 10. Millenium: Takeda Oncology1,050 11. Charles River Laboratories 970 12. AstraZeneca 900 13. EMD Serono 850 14. Hologic 800 15. Abbott Laboratories 750 16. Sunovion Pharmaceuticals (DSP) 690 17. Nova Biomedical 631 18. Cubist 626 19. Lantheus 550 19. Merck 330 20. Bristol-Myers Squibb 320 Sources: MassBio, membership reports, survey, Boston Business Journal Book of Lists, 2011. MA has benefited from the pharma industry’s embrace of biotechnology.
Mass Biomanufacturing Of the top 11 biopharma manufacturing states, Massachusetts was one of just four which added manufacturing jobs in the last decade
$4,615,364,513 in payroll (2010) $95,628 in average salary (2010) BioPharma Industry Impact in MA The estimated average salary in the biopharma industry is 77% higher than the estimated state average salary of $53,834. Source: MassExport Center Source: U.S. Census, County Business Patterns, MassBio estimate using 2009 base data.
430+ Biotech Companies 122 Colleges & Universities Top 5 NIH funded Research Hospitals 1 st in Venture Capital & SBIR funds per worker 1 st in Education Level of workforce 500+ Biopharma Companies 122 Colleges & Universities Top 5 NIH funded Research Hospitals 1 st in Venture Capital & federal research funds per worker 1 st in Education Level of Workforce (US) Why Massachusetts? Supportive Local, State Government Life Sciences Initiative Biotech Caucus
The $1 Billion Massachusetts Life Sciences Initiative 10 years $1 billion Investment $500 million Capital Fund $250 million Tax Incentive Program $250m Investment Fund (subject to appropriation) Over time, the industry demonstrated its value, commitment to the region, and promise for the future... and state government responded.
U.S. Department of Labor to receive the Trade Adjustment Assistance Community College and Career Training Grant. $20M The Metro Boston Skilled Careers in Life Sciences (SCILS) initiative $5M – Life Sciences Center & Quincy College Mass Life Science Center Internship Program - since the program first launched in 2009, the Center has placed 794 interns at more than 250 companies throughout Massachusetts! MassBioEd Foundation’s industry endorsement of eight community college programs Education and Workforce Development Initiatives
Northeast Biomanufacturers and Community Colleges with Biomanufacturing